Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neuropsychiatric condition that may be associated with negative health outcomes. This retrospective cohort study reveals the odds of hospitalization and mortality based on ASD for a population of insured patients with COVID-19. The odds of hospitalization and mort...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Amber, Van Eck, Kathryn, Copeland-Linder, Nikeea, Phuong, Karen, Belcher, Harolyn M.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077315/
https://www.ncbi.nlm.nih.gov/pubmed/37022580
http://dx.doi.org/10.1007/s10803-023-05971-2
_version_ 1785020274624692224
author Davis, Amber
Van Eck, Kathryn
Copeland-Linder, Nikeea
Phuong, Karen
Belcher, Harolyn M.E.
author_facet Davis, Amber
Van Eck, Kathryn
Copeland-Linder, Nikeea
Phuong, Karen
Belcher, Harolyn M.E.
author_sort Davis, Amber
collection PubMed
description Autism spectrum disorder (ASD) is a neuropsychiatric condition that may be associated with negative health outcomes. This retrospective cohort study reveals the odds of hospitalization and mortality based on ASD for a population of insured patients with COVID-19. The odds of hospitalization and mortality for people with ASD were found to be greater than individuals without ASD when adjusted for sociodemographic characteristics. Hospitalization and mortality was associated with a dose-response increase to comorbidity counts (1 to 5+). Odds of mortality remained greater for those with ASD when adjusting for comorbid health conditions. ASD is a risk factor for COVID-19 mortality. Comorbid health conditions play a particular role in increasing the odds of COVID-19 related hospitalization and death for ASD patients.
format Online
Article
Text
id pubmed-10077315
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-100773152023-04-06 Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder Davis, Amber Van Eck, Kathryn Copeland-Linder, Nikeea Phuong, Karen Belcher, Harolyn M.E. J Autism Dev Disord Original Paper Autism spectrum disorder (ASD) is a neuropsychiatric condition that may be associated with negative health outcomes. This retrospective cohort study reveals the odds of hospitalization and mortality based on ASD for a population of insured patients with COVID-19. The odds of hospitalization and mortality for people with ASD were found to be greater than individuals without ASD when adjusted for sociodemographic characteristics. Hospitalization and mortality was associated with a dose-response increase to comorbidity counts (1 to 5+). Odds of mortality remained greater for those with ASD when adjusting for comorbid health conditions. ASD is a risk factor for COVID-19 mortality. Comorbid health conditions play a particular role in increasing the odds of COVID-19 related hospitalization and death for ASD patients. Springer US 2023-04-06 /pmc/articles/PMC10077315/ /pubmed/37022580 http://dx.doi.org/10.1007/s10803-023-05971-2 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Davis, Amber
Van Eck, Kathryn
Copeland-Linder, Nikeea
Phuong, Karen
Belcher, Harolyn M.E.
Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder
title Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder
title_full Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder
title_fullStr Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder
title_full_unstemmed Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder
title_short Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder
title_sort hospitalization and mortality for insured patients in the united states with covid-19 with and without autism spectrum disorder
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10077315/
https://www.ncbi.nlm.nih.gov/pubmed/37022580
http://dx.doi.org/10.1007/s10803-023-05971-2
work_keys_str_mv AT davisamber hospitalizationandmortalityforinsuredpatientsintheunitedstateswithcovid19withandwithoutautismspectrumdisorder
AT vaneckkathryn hospitalizationandmortalityforinsuredpatientsintheunitedstateswithcovid19withandwithoutautismspectrumdisorder
AT copelandlindernikeea hospitalizationandmortalityforinsuredpatientsintheunitedstateswithcovid19withandwithoutautismspectrumdisorder
AT phuongkaren hospitalizationandmortalityforinsuredpatientsintheunitedstateswithcovid19withandwithoutautismspectrumdisorder
AT belcherharolynme hospitalizationandmortalityforinsuredpatientsintheunitedstateswithcovid19withandwithoutautismspectrumdisorder

Ejemplares similares